| Literature DB >> 31092696 |
Oscar P B Wiklander1,2, Meadhbh Á Brennan3,4,5, Jan Lötvall6, Xandra O Breakefield4, Samir El Andaloussi1,2.
Abstract
Extracellular vesicles (EVs) are nanometer-sized, lipid membrane-enclosed vesicles secreted by most, if not all, cells and contain lipids, proteins, and various nucleic acid species of the source cell. EVs act as important mediators of intercellular communication that influence both physiological and pathological conditions. Given their ability to transfer bioactive components and surmount biological barriers, EVs are increasingly being explored as potential therapeutic agents. EVs can potentiate tissue regeneration, participate in immune modulation, and function as potential alternatives to stem cell therapy, and bioengineered EVs can act as delivery vehicles for therapeutic agents. Here, we cover recent approaches and advances of EV-based therapies.Entities:
Mesh:
Year: 2019 PMID: 31092696 PMCID: PMC7104415 DOI: 10.1126/scitranslmed.aav8521
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956